Ocugen IncNASDAQ:OCGN
- LAST PRICE1.5000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.4900/ 30
- Ask / Lots1.5100/ 92
- Open / Previous Close1.6100 / 1.5000
- Day Range
- 52 Week Range
- Volume4,665,319
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OCGN |
|---|---|---|
| 09:32 ET | 66619 | 1.6048 |
| 09:33 ET | 16605 | 1.6001 |
| 09:35 ET | 7058 | 1.595 |
| 09:37 ET | 22806 | 1.6 |
| 09:39 ET | 7091 | 1.595 |
| 09:42 ET | 14346 | 1.5716 |
| 09:44 ET | 9486 | 1.585 |
| 09:46 ET | 41216 | 1.59 |
| 09:48 ET | 5857 | 1.585 |
| 09:50 ET | 2882 | 1.5881 |
| 09:51 ET | 37993 | 1.5797 |
| 09:53 ET | 7160 | 1.5791 |
| 09:55 ET | 3941 | 1.57 |
| 09:57 ET | 16001 | 1.5686 |
| 10:00 ET | 3984 | 1.57 |
| 10:02 ET | 4644 | 1.56 |
| 10:04 ET | 33098 | 1.56 |
| 10:06 ET | 10160 | 1.55 |
| 10:08 ET | 3000 | 1.555 |
| 10:09 ET | 15598 | 1.55 |
| 10:11 ET | 4370 | 1.5563 |
| 10:13 ET | 22100 | 1.5579 |
| 10:15 ET | 3886 | 1.55 |
| 10:18 ET | 19672 | 1.555 |
| 10:20 ET | 8857 | 1.55 |
| 10:22 ET | 9700 | 1.54 |
| 10:24 ET | 3784 | 1.545 |
| 10:26 ET | 23731 | 1.535 |
| 10:27 ET | 25334 | 1.54 |
| 10:29 ET | 1385 | 1.545 |
| 10:31 ET | 10975 | 1.53 |
| 10:33 ET | 1183 | 1.535 |
| 10:36 ET | 16618 | 1.5322 |
| 10:38 ET | 18135 | 1.53 |
| 10:40 ET | 3844 | 1.54 |
| 10:42 ET | 54422 | 1.555 |
| 10:44 ET | 60613 | 1.5568 |
| 10:45 ET | 13835 | 1.54 |
| 10:47 ET | 4737 | 1.5488 |
| 10:49 ET | 10168 | 1.5484 |
| 10:51 ET | 2641 | 1.54 |
| 10:54 ET | 3562 | 1.54 |
| 10:56 ET | 2569 | 1.545 |
| 10:58 ET | 4841 | 1.54 |
| 11:00 ET | 650 | 1.54 |
| 11:02 ET | 2892 | 1.55 |
| 11:03 ET | 5350 | 1.545 |
| 11:05 ET | 4784 | 1.55 |
| 11:07 ET | 2329 | 1.54 |
| 11:09 ET | 4325 | 1.54 |
| 11:12 ET | 4590 | 1.545 |
| 11:14 ET | 75571 | 1.5501 |
| 11:16 ET | 21371 | 1.545 |
| 11:18 ET | 12092 | 1.54 |
| 11:20 ET | 3990 | 1.54 |
| 11:21 ET | 1100 | 1.54 |
| 11:23 ET | 15807 | 1.545 |
| 11:25 ET | 13458 | 1.54 |
| 11:27 ET | 20124 | 1.545 |
| 11:30 ET | 2130 | 1.545 |
| 11:32 ET | 2500 | 1.54 |
| 11:34 ET | 53355 | 1.53 |
| 11:36 ET | 40062 | 1.53 |
| 11:38 ET | 6614 | 1.535 |
| 11:39 ET | 9700 | 1.535 |
| 11:41 ET | 49690 | 1.535 |
| 11:43 ET | 1216 | 1.535 |
| 11:45 ET | 3048 | 1.53 |
| 11:48 ET | 6811 | 1.535 |
| 11:50 ET | 2659 | 1.535 |
| 11:52 ET | 2800 | 1.53 |
| 11:54 ET | 4712 | 1.53 |
| 11:56 ET | 11142 | 1.53 |
| 11:57 ET | 14335 | 1.53 |
| 11:59 ET | 9882 | 1.535 |
| 12:01 ET | 9888 | 1.53 |
| 12:03 ET | 6626 | 1.535 |
| 12:06 ET | 4092 | 1.5377 |
| 12:08 ET | 4110 | 1.535 |
| 12:10 ET | 1833 | 1.53 |
| 12:12 ET | 3302 | 1.53 |
| 12:14 ET | 3397 | 1.535 |
| 12:15 ET | 2513 | 1.53 |
| 12:17 ET | 1400 | 1.53 |
| 12:19 ET | 4871 | 1.53 |
| 12:21 ET | 3900 | 1.53 |
| 12:24 ET | 1909 | 1.535 |
| 12:26 ET | 2916 | 1.53 |
| 12:28 ET | 6055 | 1.53 |
| 12:30 ET | 3821 | 1.535 |
| 12:32 ET | 13221 | 1.53 |
| 12:33 ET | 1003 | 1.53 |
| 12:35 ET | 29525 | 1.53 |
| 12:37 ET | 500 | 1.53 |
| 12:39 ET | 118433 | 1.515 |
| 12:42 ET | 6630 | 1.52 |
| 12:44 ET | 950 | 1.51 |
| 12:46 ET | 14606 | 1.5115 |
| 12:48 ET | 6142 | 1.515 |
| 12:50 ET | 7498 | 1.515 |
| 12:51 ET | 5048 | 1.5109 |
| 12:53 ET | 54228 | 1.5 |
| 12:55 ET | 54973 | 1.495 |
| 12:57 ET | 16604 | 1.495 |
| 01:00 ET | 6558 | 1.49 |
| 01:02 ET | 13671 | 1.495 |
| 01:04 ET | 13714 | 1.495 |
| 01:06 ET | 2990 | 1.495 |
| 01:08 ET | 4633 | 1.49 |
| 01:09 ET | 40993 | 1.4979 |
| 01:11 ET | 13771 | 1.49 |
| 01:13 ET | 6245 | 1.495 |
| 01:15 ET | 9047 | 1.495 |
| 01:18 ET | 119523 | 1.5 |
| 01:20 ET | 1357 | 1.5 |
| 01:22 ET | 14074 | 1.495 |
| 01:24 ET | 5198 | 1.495 |
| 01:26 ET | 12110 | 1.495 |
| 01:27 ET | 13561 | 1.495 |
| 01:29 ET | 6158 | 1.4954 |
| 01:31 ET | 3100 | 1.49 |
| 01:33 ET | 5367 | 1.49 |
| 01:36 ET | 3899 | 1.49 |
| 01:38 ET | 8574 | 1.49 |
| 01:40 ET | 7075 | 1.495 |
| 01:42 ET | 6757 | 1.495 |
| 01:44 ET | 38371 | 1.495 |
| 01:45 ET | 9497 | 1.495 |
| 01:47 ET | 2253 | 1.49 |
| 01:49 ET | 2520 | 1.4952 |
| 01:51 ET | 3203 | 1.49 |
| 01:54 ET | 16407 | 1.4901 |
| 01:56 ET | 9548 | 1.49 |
| 01:58 ET | 58572 | 1.4804 |
| 02:00 ET | 23052 | 1.48 |
| 02:02 ET | 22401 | 1.48 |
| 02:03 ET | 7091 | 1.485 |
| 02:05 ET | 7095 | 1.48 |
| 02:07 ET | 4441 | 1.48 |
| 02:09 ET | 14317 | 1.48 |
| 02:12 ET | 6682 | 1.48 |
| 02:14 ET | 2600 | 1.48 |
| 02:16 ET | 2174 | 1.48 |
| 02:18 ET | 4245 | 1.48 |
| 02:20 ET | 13453 | 1.48 |
| 02:21 ET | 5722 | 1.48 |
| 02:23 ET | 1930 | 1.48 |
| 02:25 ET | 14375 | 1.485 |
| 02:27 ET | 6921 | 1.49 |
| 02:30 ET | 11339 | 1.485 |
| 02:32 ET | 12825 | 1.48 |
| 02:34 ET | 152241 | 1.47 |
| 02:36 ET | 9098 | 1.47 |
| 02:38 ET | 1868 | 1.475 |
| 02:39 ET | 8258 | 1.475 |
| 02:41 ET | 2429 | 1.47 |
| 02:43 ET | 20059 | 1.465 |
| 02:45 ET | 78169 | 1.47 |
| 02:48 ET | 28979 | 1.47 |
| 02:50 ET | 13304 | 1.48 |
| 02:52 ET | 19320 | 1.48 |
| 02:54 ET | 12219 | 1.48 |
| 02:56 ET | 5671 | 1.475 |
| 02:57 ET | 4200 | 1.47 |
| 02:59 ET | 6335 | 1.475 |
| 03:01 ET | 2731 | 1.475 |
| 03:03 ET | 6689 | 1.475 |
| 03:06 ET | 30685 | 1.46 |
| 03:08 ET | 34041 | 1.465 |
| 03:10 ET | 11854 | 1.465 |
| 03:12 ET | 29408 | 1.465 |
| 03:14 ET | 7777 | 1.465 |
| 03:15 ET | 46998 | 1.45 |
| 03:17 ET | 12278 | 1.45 |
| 03:19 ET | 10341 | 1.45 |
| 03:21 ET | 64296 | 1.45 |
| 03:24 ET | 47244 | 1.4483 |
| 03:26 ET | 20404 | 1.445 |
| 03:28 ET | 24324 | 1.4457 |
| 03:30 ET | 18134 | 1.4483 |
| 03:32 ET | 28529 | 1.445 |
| 03:33 ET | 22702 | 1.4492 |
| 03:35 ET | 80974 | 1.4599 |
| 03:37 ET | 37643 | 1.4599 |
| 03:39 ET | 21315 | 1.455 |
| 03:42 ET | 56792 | 1.4501 |
| 03:44 ET | 25007 | 1.45 |
| 03:46 ET | 16522 | 1.45 |
| 03:48 ET | 19241 | 1.4585 |
| 03:50 ET | 38223 | 1.4575 |
| 03:51 ET | 226503 | 1.4786 |
| 03:53 ET | 88381 | 1.485 |
| 03:55 ET | 113938 | 1.4901 |
| 03:57 ET | 74550 | 1.495 |
| 04:00 ET | 741256 | 1.5 |
Nov 28, 2022
Ocugen to Present at 3rd Annual Dry AMD Therapeutics Summit, from 7:30AM ET on Monday Nov 28, 2022 by GlobeNewswire
7:30AM ET on Monday Nov 28, 2022 by GlobeNewswire
Nov 8, 2022
BRIEF-Ocugen Reports Third Quarter Results, from 8:38AM ET on Tuesday Nov 08, 2022 by Thomson Reuters
8:38AM ET on Tuesday Nov 08, 2022 by Thomson ReutersOcugen Provides Business Update & Third Quarter 2022 Financial Results, from 7:30AM ET on Tuesday Nov 08, 2022 by GlobeNewswire
7:30AM ET on Tuesday Nov 08, 2022 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ocugen Inc | 352.4M | -4.3x | --- |
PepGen Inc | 353.1M | -5.6x | --- |
Generation Bio Co | 355.9M | -2.2x | --- |
Cymabay Therapeutics Inc | 348.0M | -3.3x | --- |
Eloxx Pharmaceuticals Inc | 357.9M | -0.2x | --- |
Centessa Pharmaceuticals PLC | 365.1M | -1.6x | --- |
Company Information
Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine candidate is focused on developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the Ocugen Covaxin Territory. COVAXIN is a whole-virion inactivated COVID-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus. The Modifier Gene Therapy platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). It is developing OCU200, a biologic product candidate to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet AMD. OCU400, its first product candidate being developed with its modifier gene therapy platform.
Contact Information
- Headquarters
- 11 GREAT VALLEY PARKWAYMALVERN, PA, United States 19355
- Phone
- 484-328-4701
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer
- Shankar Musunuri
- Senior Vice President - Finance, Chief Accounting Officer
- Jessica Crespo
- Senior Vice President - Regulatory Affairs, compliance and safety
- Nirdosh Jagota
- Senior Vice President - Regulatory and Quality
- Vijay Tammara
- Director
- Marna Whittington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $328.3M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 218.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.99 |
EPS | $-0.35 |
Book Value | $0.48 |
P/E Ratio | -4.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
